{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:19:33Z","timestamp":1782303573130,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jns.2005.09.004","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T07:20:50Z","timestamp":1129620050000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: A case-control study"],"prefix":"10.1016","volume":"240","author":[{"given":"Wenxiang","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kazui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kakigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.09.004_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.pu.13.050192.002243","article-title":"Cognitive impairment: dementia and Alzheimer's disease","volume":"13","author":"Larson","year":"1992","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jns.2005.09.004_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.09.004_bib3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.09.004_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0594-74","article-title":"Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease","volume":"7","author":"van Duijn","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jns.2005.09.004_bib6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2005.09.004_bib7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.09.004_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1196\/annals.1299.118","article-title":"A proximal gene promoter region for the beta-amyloid precursor protein provides a link between development, apoptosis, and Alzheimer's disease","volume":"1010","author":"Lahiri","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jns.2005.09.004_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/archneur.59.11.1793","article-title":"Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease","volume":"59","author":"Athan","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2005.09.004_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jnnp.66.6.722","article-title":"A case-control study of presenilin-1 intronic polymorphism in sporadic early- and late-onset Alzheimer's disease","volume":"66","author":"Yasuda","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2005.09.004_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.ejhg.5200373","article-title":"Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample","volume":"7","author":"van Duijn","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/hmg\/ddg098","article-title":"Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression","volume":"12","author":"Theuns","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.mp.4001097","article-title":"Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E","volume":"7","author":"Laws","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jns.2005.09.004_bib14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/hmg\/7.12.1887","article-title":"Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene","volume":"7","author":"Artiga","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/hmg\/7.9.1511","article-title":"Pronounced impact of Th1\/E47cs mutation compared with-491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease","volume":"7","author":"Lambert","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.59.1.59","article-title":"Contribution of APOE promoter polymorphisms to Alzheimer's disease risk","volume":"59","author":"Lambert","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.09.004_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200513","article-title":"APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population","volume":"8","author":"Zurutuza","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s004150050461","article-title":"Promoter polymorphism (\u2212491A\/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals","volume":"246","author":"Helisalmi","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2005.09.004_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.mp.4001101","article-title":"Regulatory region variability in the human presenilin-2 (PSEN) gene: potential contribution to the gene activity and risk for AD","volume":"7","author":"Riazanskaia","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jns.2005.09.004_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(03)00335-5","article-title":"Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian population","volume":"343","author":"Di Natale","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2005.09.004_bib21","first-page":"1159","article-title":"Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET","volume":"37","author":"Ishii","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jns.2005.09.004_bib22","first-page":"77","article-title":"Apolipoprotein E \u03b54 allele and gender difference in risk of Alzheimer's disease","volume":"1","author":"Yasuda","year":"1995","journal-title":"Alzheimer's Res"},{"key":"10.1016\/j.jns.2005.09.004_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State: a practical method for grading the cognitive state for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jns.2005.09.004_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.09.004_bib25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","article-title":"Apolipoprotein E genotyping by one-stage PCR","volume":"337","author":"Wenham","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.09.004_bib26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archneur.60.11.1521","article-title":"Alzheimer disease genes: presenilin 2 mutation number 9 and still counting","volume":"60","author":"Schellenberg","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2005.09.004_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","article-title":"Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant","volume":"5","author":"Sherrington","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","article-title":"Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease","volume":"7","author":"Cruts","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/6.10.1639","article-title":"The presenilins and Alzheimer's disease","volume":"6","author":"Hutton","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2005.09.004_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ajmg.b.30087","article-title":"APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation","volume":"132B","author":"Wijsman","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05003357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05003357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:37:18Z","timestamp":1758382638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X05003357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0022510X05003357"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.09.004","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2005.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}